BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Ultimate Trader

1 year 40%, 2 years 50% and *3 years 60%

*Across 3 years $3395.52 only $1358.21

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,998.74
      -0.38%
      US Tech 100
      20,239.20
      -0.65%
      Dow Jones
      44,722.06
      -0.31%
      Brent Oil
      72.155
      -0.33%
      Bitcoin
      95,199.89
      -0.81%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. CSE

      6. Defence Therapeutics Inc (DTC) Quote

      Defence Therapeutics Inc

      Defence Therapeutics Inc (DTC)

      Damstra Holdings Limited
      Solo Brands Inc
      Defence Therapeutics Inc
      0.54
      0.00
      (0.00%)
      Closed November 27 4:00PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.54
      Bid
      0.51
      Ask
      0.55
      Volume
      -
      0.00 Day's Range 0.00
      0.48 52 Week Range 2.85
      Previous Close
      0.54
      Open
      -
      Last Trade
      Last Trade Time
      Average Volume (3m)
      24,474
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      DTC Latest News

      More News

      DEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER

       DEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER  Vancouver, BC, Canada, February 16th, 2022 -- InvestorsHub NewsWire Defence Therapeutics Inc...

      February 16 2022
      InvestorsHub NewsWire

      Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9

        Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9   Vancouver, BC, Canada, January 26th...

      January 26 2022
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENT

      Vancouver, BC, Canada -- November 30th 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. (CSE: DTC; FSE: DTC; USOTC: DTCFF) ("Defence" or the...

      November 30 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER

      DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER   Vancouver, BC, Canada -- November 23, 2021 -- InvestorsHub NewsWire...

      November 23 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS

       DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS Vancouver, BC, Canada, November 9th, 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. CSE:DTC, USOTC:DTCFF...

      November 09 2021
      InvestorsHub NewsWire

      VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS

        VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS   Vancouver, BC, Canada, November...

      November 03 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER

        DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER   Vancouver, BC, Canada, October 13th...

      October 13 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMA

          DEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMA Vancouver, BC, Canada, October 6th, 2021 -- InvestorsHub NewsWire -- Defence...

      October 06 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCER

       DEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCER Vancouver, BC, Canada, September 29th, 2021 - InvestorsHub NewsWire -- Defence Therapeutics Inc...

      September 29 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS

       DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS Vancouver, BC, Canada, September 20th, 2021 -- InvestorsHub NewsWire -- Defence...

      September 20 2021
      InvestorsHub NewsWire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.01-1.818181818180.550.570.5172560.51199829CS
      4-0.08-12.90322580650.620.670.51199040.57441277CS
      12-0.02-3.571428571430.560.670.48244740.57754097CS
      26-0.66-551.21.20.48315980.73678017CS
      52-2.14-79.85074626872.682.850.48289151.18006076CS
      156-4.95-90.16393442625.495.80.48190662.1815763CS
      260-1.21-69.14285714291.758.150.48183772.6067915CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      METLMetalite Resources Inc
      $ 0.05
      (400.00%)
      		620.56k
      VCVolatus Capital Corp
      $ 0.01
      (100.00%)
      		742k
      BEEBee Vectoring Technologies International Inc
      $ 0.01
      (100.00%)
      		160k
      TRAITrilogy AI Corp
      $ 0.09
      (63.64%)
      		36k
      CLSHCLS Holdings USA Inc
      $ 0.095
      (58.33%)
      		4.53k
      CURE.XBiocure Technology Inc
      $ 0.01
      (-66.67%)
      		3k
      VTALJustera Health Ltd
      $ 0.005
      (-50.00%)
      		50k
      TONETriple One Metals Inc
      $ 0.005
      (-50.00%)
      		148.5k
      ENRTEnertopia Corp
      $ 0.005
      (-50.00%)
      		29.3k
      ACRG.A.UAcreage Holdings Inc
      $ 0.005
      (-50.00%)
      		220.51k
      SPMTSpearmint Resources Inc
      $ 0.025
      (25.00%)
      		4.34M
      CLDVCloud3 Ventures Inc
      $ 0.015
      (-40.00%)
      		3.9M
      CSSCascada Silver Corp
      $ 0.04
      (0.00%)
      		2.21M
      PRMEPrime Drink Group Corp
      $ 0.315
      (0.00%)
      		2.05M
      MILIMilitary Metals Corp
      $ 0.375
      (8.70%)
      		1.95M

      DTC Discussion

      View Posts
      Man6677 Man6677 3 years ago
      Why are there no trades here ?

      Thank you !

      Great news today !
      👍️0
      newspopper newspopper 3 years ago
      Get in KITL .08-.10 news will be poppin
      👍️0
      newspopper newspopper 3 years ago
      Need more volume for Poppin action
      👍️0
      newspopper newspopper 3 years ago
      Looking for FDA Poppin news
      👍️0
      newspopper newspopper 3 years ago
      KITL news going to be poppin
      👍️0
      GOLDBUFFALO GOLDBUFFALO 3 years ago
      Seems to be a very interesting stock.
      👍️0

      Your Recent History

      CSE
      DTC
      Defence Therapeutics
      BIT
      I10542
      IT0005616864 20250602 46
      Delayed Upgrade Clock